Bio-Rad Laboratories, Inc. (BIO) stock rallied over 0.75% intraday to trade at $506.10 a share on NYSE. The stock opened with a gain of 3.15% at $495.01 and touched an intraday high of $503.48, rising 2.24% against the last close of $495. The stock went to a low of $491.44 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue2.9 Billion
5Y Sales Change7.20%
Fiscal Year Ends2021-12-30
IndustryLife Sciences Tools and Services
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Bio-Rad Laboratories, Inc. (NYSE: BIO) stock price is $506.1 as of the last check on Friday, July 1. During the trading session, BIO stock reached the peak price of $503.48 while $491.44 was the lowest point it dropped to.
The NYSE listed BIO is part of Life Sciences Tools and Services industry that operates in the broader Health Care sector. Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America.
Mr. Norman D. Schwartz
Chairman, CEO & Pres
Mr. Ilan Daskal
Exec. VP & CFO
Dr. Andrew J. Last
Exec. VP & COO
Mr. Michael Crowley
Exec. VP of Global Commercial Operations
BIO stock traded closed the last session at $502.34, which is $3.76 or 0.75% lower than its previous close of $495. BIO's current trading price is 9.40% lower than its 52-week high of $832.70 where as its distance from 52-week low of 462.61% is -39.22%.
Number of BIO employees currently stands at -. BIO operates from 1000 Alfred Nobel Drive, Hercules, CA 94547, United States.
Official Webiste of $BIO is: https://www.bio-rad.com
BIO stock volume for the day was 113,168 shares while in the previous session number of BIO shares traded was 116,800 . The average number of BIO shares traded daily for last 3 months was 216.6 Thousands.
The percentage change in BIO stock occurred in the recent session was 0.75% while the dollar amount for the price change in BIO stock was $3.76.
In the recent session, the day high for BIO stock was $503.48 while the low for BIO stock touched on the day was $491.44.
The market value of BIO currently stands at 14.7 Billion with its latest stock price at $506.1 and 29.93 Million of its shares outstanding.